Epstein Secrets

s to allow minors into a vaccine trial." Palantir System To Help Track Manufacture, Distribution Of COVID Vaccines. The Wall Street Journal (10/22, Loftus, Winkler, Subscription Publication, 7.57M) reports that according to state and local health officials, Palantir Technologies, a data-mining company,

scrutiny "is critical to build trust and confidence" in whichever vaccines emerge. Pfizer Expands Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, ai

d the pandemic." The Wall Street Journal <https://www.wsj.corn/articles/modernas-coronavirus-vaccine-begins-final-stage-testing- 11595854440> (7/27, Loftus, Subscription Publication, 7.57M) reports that NIH's Collins said on Monday, "Yes, we're going fast, but no, we are not going to compromise safety o

vaccine before." USA Today <https://www.usatoday.corn/stoty/news/2020/07/27/large-scale-trials- possible-covid-19-vaccines-begin/5518981002/> (7/27, Weintraub, 10.31M), the Washington Times <https://www.washingtontimes.corn/news/2020/jul/27/virus-vaccine-put-to-final-test-in-thousands-of-vo/> (7/27, Neerg

ibution Of COVID Vaccines. The Wall Street Journal <https://www.wsj.corn/articles/palantir-to-help-u-s-track-covid-19-vaccines- 11603367276> (10/22, Loftus, Winkler, Subscription Publication, 7.57M) reports that according to state and local health officials, Palantir Technologies, a data-mining company,

eens. USA Today <https://www.usatoday.com/story/news/health/2020/10/22kovid-vaccine-children-clinical-trials-pfizer- cincinnati/3709031001/> (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aim

d the Wall Street Journal <https://www.wsj.corn/articles/modema-to-ask-health-regulators-to-authorize-its-covid-19-vaccine- 11606737602> (11/30, Al, Loftus, Subscription Publication, 7.57M), "I think this vaccine is going to be really a game changer for this pandemic." Bancel added, "We think it can rea

" USA Today <https://www.usatoday.corn/story/news/health/2020/11/30/modema-emergency-fda-authorization- covid-19-vaccine-pfizer/6376336002/> (11/30, Weintraub, 10.31M) reports Modema's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placebo

ons given the complications and slower-than-hoped rollout of authorized vaccines" from Pfizer and Moderna. The Wall Street Journal (1/26, Grossman, Loftus, Subscription Publication, 8.41M) reports J&J discussed its vaccine plans Tuesday as it reported fourth-quarter earnings. Eli Lilly Reports Positiv

in newly diagnosed, non-hospitalized COVID-19 patients at high risk of serious illness because of age or other health conditions." USA Today (1/26, Weintraub, 12.7M) reports Lilly's drug bamlanivimab was authorized by the FDA "late last year and has been used by 125,000 high-risk patients nationwide based

s to allow minors into a vaccine trial." Palantir System To Help Track Manufacture, Distribution Of COVID Vaccines. The Wall Street Journal (10/22, Loftus, Winkler, Subscription Publication, 7.57M) reports that according to state and local health officials, Palantir Technologies, a data-mining company,

scrutiny "is critical to build trust and confidence" in whichever vaccines emerge. Pfizer Expands Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, ai

accinations "may be given as early as Dec. 21 if the process goes smoothly and approval is granted." Bancel told the Wall Street Journal (11/30, Al, Loftus, Subscription Publication, 7.57M), "I think this vaccine is going to be really a game changer for this pandemic." Bancel added, "We think it can re

stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster 'conditional' clearance." USA Today (11/30, Weintraub, 10.31M) reports Moderna's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placeb

nt of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic." The Wall Street Journal (7/27, Loftus, Subscription Publication, 7.57M) reports that NIH's Collins said on Monday, "Yes, we're going fast, but no, we are not going to compromise safety

fight the virus," and "while early studies show promise, mRNA technology has never been used to make a successful vaccine before." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other ne

nt of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic." The Wall Street Journal (7/27, Loftus, Subscription Publication, 7.57M) reports that NIH's Collins said on Monday, "Yes, we're going fast, but no, we are not going to compromise safety

fight the virus," and "while early studies show promise, mRNA technology has never been used to make a successful vaccine before." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other ne

accinations "may be given as early as Dec. 21 if the process goes smoothly and approval is granted." Bancel told the Wall Street Journal (11/30, Al, Loftus, Subscription Publication, 7.57M), "I think this vaccine is going to be really a game changer for this pandemic." Bancel added, "We think it can re

stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster `conditional' clearance." USA Today (11/30, Weintraub, 10.31M) reports Moderna's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placeb